Michael Andrew Chambers Sarepta Therapeutics, Inc. (SRPT) insider trading activity
Michael Andrew Chambers is of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 8,277 shares of SRPT, which is worth approximately $1.07 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 1,846 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
8.28K
0%
3M change
28.7%
12M change
Total Value Held
$1.07 Million
Michael Andrew Chambers Transaction History
MAC
Michael Andrew Chambers
Cambridge, MA